Searched for
FORMULATION MANUFACTURING FACILITY
Aurobindo Pharma arm Eugia Pharma's Telangana unit gets warning letter from USFDAAurobindo Pharma announced its subsidiary Eugia Pharma received a USFDA warning letter. This follows an inspection of their Telangana formu...- Swadeshi 1.0 vs. Made in India 2.0: How India turned a 1905 boycott into a 2026 business strategyIndependence Day 2026: From the Swadeshi movement to Atmanirbhar Bharat. Early Swadeshi movements fostered indigenous industries against im...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat is volatility? There is, of course, a mathematical definition. Then there is the human definition, which is how investors feel it. In ...
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
- Shein finds there's no place like China after Vietnam warehouse experiment disappointsU.S. exemptions for duties on small parcels from China that underpinned its business model looked as if they would be abolished, Donald Tru...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsA word of caution for all those who have exposure to mid cap stocks or are planning to increase it. Just keep one thing in mind: If there i...
- Private equity firm Creador in talks to buy into generic drug co Leeford HealthPrivate equity firm Creador is in advanced talks to acquire a stake. The firm expects to invest ₹800 crore in Leeford Healthcare. This acqu...
- BDR Pharmaceuticals eyes controlling stake in Acme FormulationPAG acquired a controlling stake in Acme Formulation for $145 million (?1,054 crore) through its PAG Asia III buyout fund in 2021. Founder ...
- Unexpected gainer of trouble in the Gulf? 13 stocks from backend of the EV shift, with upside potential of up to 33%Most investors seeking exposure to the EV shift choose the obvious: A pure EV company; a scooter or car maker. They are the face of the tra...
- Indian pharma firms may yet survive Trump's 200% tariff bombshellDonald Trump's proposed up to 200% tariff on generic drug imports has raised concerns for Indian pharma companies, but industry experts say...
- 200% Trump tariff shock? India’s cheap pills may still beat US rivalsUS President Donald Trump's proposed tariffs of up to 200% on imported generic medicines could put pressure on India's pharmaceutical expor...
- Bengaluru-based STEER World bags Rs 60 crore export order for lithium-ion battery separator project in ChinaBengaluru-based STEER World secured a significant export order valued at Rs 60 crore. This order is for a lithium-ion battery separator man...
- Dolly Khanna portfolio rejig: Ace investor likely exits 2 stocks, pares holding in Prakash Industries in Q1Ace investor Dolly Khanna likely exited Rain Industries and Sharda Cropchem during the June quarter after strong gains of up to 42% this ye...
- For investors with high risk-appetite: 5 mid-cap stocks from different sectors with upside potential of up to 21%Brace for trouble. The US-Iran conflict now appears to be gaining in intensity and the commodities market is taking the current spiral of v...
- Iceberg bets on organic sourcing and clean labels to build a Rs 100-cr ice cream brandAs India's premium ice cream market shifts from calorie-counting to ingredient-conscious consumption, Iceberg Organic Ice Creams is betting...
- Dr Reddy’s pauses weight loss drug on quality fearsDr Reddy's Laboratories will halt semaglutide injection supplies until at least October. Unspecified impurities were identified during the ...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 25%As the market makes an attempt to move upward, there is a clear preference for sectors that are focused on the domestic market. Given this,...
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsIn just a few days, the Q1 earnings season for FY27 will start. But before that will come the season of business updates. And that needs to...
- Shantha Biologics to make injectable drug cartridges for Novo NordiskShantha Biologics has secured a significant contract with Danish pharmaceutical giant Novo Nordisk to manufacture cartridges for injectable...
- CM Yogi woos investors to UP with incentives, 75,000-acre land bank, single-window systemUttar Pradesh Chief Minister Yogi Adityanath urged domestic and global investors to explore the state's vast opportunities, highlighting a ...
Load More
